Pfizer COVID-19 vaccine rolls off production line amid hopes for emergency approval
Pfizer has released footage of a potential coronavirus vaccine rolling off the production line — as the drug giant aims to have 100 million doses ready by the end of the year.
The Manhattan-based company told the Mail on Sunday that it has already made “several hundred thousand doses” of the drug as it prepares to seek emergency use in the US by November.
The firm’s UK boss, Ben Osborn, also told the paper that scientists in its main British lab have also unearthed drugs that could provide a potential complete cure for Covid-19, as opposed to merely a preventative vaccine.
Osborn said the company is manufacturing the huge stockpile of its current vaccine candidate in Belgium “at risk and at scale,” calling it “tremendously exciting.”
“The hope here is that we essentially come up with a medicine that disrupts the virus and ultimately prevents it worsening the condition of a patient,” he told the Mail’s financial site, This is Money.
No comments:
Post a Comment